Impax Laboratories (IPXL) News Today → Trump’s last act as President (From Porter & Company) (Ad) Free IPXL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineImpax Sustainable Allocation Fund Investor Class (PAXWX)investing.com - September 10 at 12:14 PMKBLB Kraig Biocraft Laboratories, Inc.seekingalpha.com - May 23 at 8:25 PMFerozsons Laboratories Ltd.wsj.com - May 11 at 12:04 AMImpax Ellevate Global Women's Leadership Fund;Individual Investorwsj.com - April 5 at 3:34 PMImpax Stock Hits New 52-Week High (IPXL)thestreet.com - April 3 at 10:16 AMImpax CEO Says Funds Have Run Out of 'Investible' Green Assetsfinancialpost.com - March 28 at 3:58 PMMorepen Laboratories Ltd (MORL)investing.com - September 29 at 10:26 PMAbbott Laboratories (NYSE: ABT)fool.com - September 9 at 7:28 PMClearside Biomedical Inc. Newsthestreet.com - July 27 at 8:18 AM Get Impax Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for IPXL and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 IPXL Media Mentions By Week IPXL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPXL News Sentiment▼0.000.34▲Average Medical News Sentiment IPXL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPXL Articles This Week▼00▲IPXL Articles Average Week Get Impax Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for IPXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Context Therapeutics News Today Grifols News Today LAVA Therapeutics News Today Mainz Biomed News Today NLS Pharmaceutics News Today Pharvaris News Today Procaps Group News Today Qilian International Holding Group News Today Tiziana Life Sciences News Today Aclarion News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IPXL) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Report😱 This phenomenon is smashing regular market gainsMillPubForget Nvidia. This is the future of AIPorter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Impax Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
